Sources and methodology

Introduction

Please see below for an overview of the data sources used for the metrics within the ABPI’s Pharma Impact Map, as well as the methodologies applied to process the data for each metric.

 

Economy

Manufacturing sites:

Data source(s)

Data details

Bioscience and health technology sector statistics (BaHTSS) dataset.

BaHTSS 2021 site-level data provides detailed information about sites within the bioscience and health technology sector.

Methodology:

  1. To identify biopharmaceutical manufacturing sites, a filter was applied to identify biopharmaceutical companies, with manufacturing organisations identified from the business activity codes.

  2. The site postcode information available in the dataset was used for geographical mapping purposes at a local and regional level.

Source URL:

https://www.gov.uk/government/statistics/bioscience-and-health-technology-sector-statistics-2021

Note: Sites identified via the tool will include a combination of biopharmaceutical companies manufacturing medicines and vaccines, and capture some companies within the service and supply sector which provide key input materials, or part of the medicines manufacturing process. See methodology:

 

Jobs

Data source(s)

Data details

ONS

The dataset provides Census 2021 estimates that classify usual residents aged 16 years and over in employment the week before the census in England and Wales by industry. Estimates are as at Census Day, 21 March 2021.

Methodology:

  1. The Fraser of Allander Institute report (Feb 2023) [1] was used to identify SIC07 codes, and their respective percentages related to the UK biopharmaceutical industry.

    1. SIC21: Manufacture of basic pharmaceutical products and pharmaceutical preparations (100%)

    2. SIC72: Scientific research and development (12%)

  2. For the purposes of this tool, it has been assumed that the composition of SIC07 codes representing the biopharmaceutical industry remains the same across all regions within the UK.

  3. The ONS data source includes data on employment sector for England and Wales at constituency level.

  4. Biopharmaceutical industry employment in Scotland was identified using the Fraser of Allander Institute – The economic contribution of the Pharmaceuticals Sector in Scotland (Feb 2023) [1].

    1. The value of full-time equivalent (FTE) employment in the wider pharmaceutical sector was used. The composition of SIC07 codes defining the wider pharmaceutical sector in ‘The economic contribution of the Pharmaceuticals Sector in Scotland’ (Feb 2023) [1] is as follows:

      1. SIC21: Manufacture of basic pharmaceutical products and pharmaceutical preparations (100%)

      2. SIC46: Wholesale trade, except for motor vehicles and motorcycles (0.51%)

      3. SIC70: Activities of head offices; management consultancy activities (0.02%)

      4. SIC72: Scientific research and development (12%)

    2. The contribution of FTE from SIC46 and SIC70 is not specified in ‘The economic contribution of the Pharmaceuticals Sector in Scotland’ (Feb 2023) [1]. Therefore, SIC46 and SIC70 are included in the final value of biopharmaceutical industry employment in Scotland.
  1. Northern Ireland biopharmaceutical industry employment was identified using the Fraser of Allander Institute - The Economic Contribution of the Pharmaceuticals Sector in Northern Ireland (May 2022) [2].

    1. The value of full-time equivalent (FTE) employment in the wider pharmaceutical sector was used. The composition of SIC07 codes defining the wider pharmaceutical sector in ‘The Economic Contribution of the Pharmaceuticals Sector in Northern Ireland’ (May 2022) [2] is as follows:

      1. SIC21: Manufacturing of basic pharmaceuticals products and pharmaceutical preparations

      2. SIC 46.46: Wholesale of pharmaceutical goods

      3. SIC72: Scientific research and development
  1. The contribution of FTE from SIC 46.46 is not specified in ‘The Economic Contribution of the Pharmaceuticals Sector in Northern Ireland’ (May 2022) [2]. Hence, SIC 46.46 is included in the final value of biopharmaceutical industry employment in Northern Ireland.

Source URLs:

https://www.ons.gov.uk/datasets/TS060/editions/2021/versions/1

https://fraserofallander.org/wp-content/uploads/2023/02/The-Economic-Contribution-of-the-Pharmaceutical-Sector-to-Scotlands-Economy-2023.pdf

https://fraserofallander.org/wp-content/uploads/2022/05/FAI-The-economic-contribution-of-the-pharmaceutical-sector-in-Northern-Ireland-FOR-SHARING.pdf

 

Percentage of pharmaceutical jobs

Data source(s)

Data details

ONS

The dataset provides Census 2021 estimates that classify usual residents aged 16 years and over in employment the week before the census in England and Wales by industry. Estimates are as at Census Day, 21 March 2021.

Scottish Government

The data source provides a report detailing Census 2021 estimates of employment of Scottish residents ages 16 years and over [4].

NISRA

This dataset provides Census 2021 estimates that classify usual residents aged 16 years and over in employment the week before the census in Northern Ireland by industry, and by sex. The estimates are as at census day, 21 March 2021.

Methodology:

  1. The numerator is the number of biopharmaceutical industry jobs for a given geography, please refer to the Jobs section above.

  2. The denominator is the total observed jobs for the same geography.

    1. Total observed jobs for England and Wales were identified from the ONS data source; this data is available at the constituency level.

    2. Total observed jobs for Scotland were obtained from GOV Scotland; this figure was provided at a regional level [4].

    3. Total observed jobs for Northern Ireland were obtained from the NISRA. The identified value represents the regional figure for total observed jobs for Northern Ireland.

Source URLs:

https://www.ons.gov.uk/datasets/TS060/editions/2021/versions/1

https://www.nisra.gov.uk/system/files/statistics/census-2021-ms-h06.xlsx

https://www.gov.scot/publications/scotlands-labour-market-people-places-regions-protected-characteristics-statistics-annual-population-survey-2021/   

 

Value added through employment in your area (gross value added (GVA)

Data source(s)

Data details

ONS

ONS national (England, Scotland, Wales and Northern Ireland) gross value added (balanced) by industry (2021) - ITL1 & UK, current price estimates, pounds million table.

Methodology:

  1. The available data for this metric was at a ITL1 (regional) level.

  2. Using ONS ITL1 (regional)GVA by industry data (2021), the total GVA for the biopharmaceutical industry was calculated by summing SIC21 (100%) and SIC72 (12%).

  3. The average gross value added per industry job was calculated at a country- level (England, Scotland, Northern Ireland and Wales) using ITL1 level data. These averages were used to compute the value added through employment at a constituency level for England and Wales.

Due to constituency level jobs data being unavailable for Scotland and Northern Ireland, for the purposes of this tool, distribution of GVA has been allocated on the basis of an even ‘per-head’ of population distribution of pharmaceutical jobs. Constituency level data on employment, jobs and GVA should not be regarded as accurate.

Source URL:

https://www.ons.gov.uk/economy/grossvalueaddedgva/datasets/nominalandrealregionalgrossvalueaddedbalancedbyindustry

 

NHS/Industry Collaborations

NHS/Industry Collaborations

Data source(s)

Data details

ABPI Disclosure UK data

Healthcare organisation 2021 disclosure data (Data accessed: 16/06/2023)

Methodology:

  1. Identification of NHS/Industry collaborations. Partnerships with specifically NHS organisations were identified from the 2021 Disclosure UK healthcare organisation data using a range of automated search terms.This dataset served as the primary source for identifying the collaborations between NHS organisations and the pharmaceutical industry.

  2. Geographical Mapping. The postcode of the partner NHS organisation was used for mapping the partnership.

Note: The Disclosure UK dataset captures values disclosed by pharmaceutical companies abiding by the ABPI Code of Practice for the Pharmaceutical Industry only. Whilst search terms applied to this dataset are expected to identify the vast majority of NHS/industry collaborations which have been disclosed via ‘Disclosure UK’, some NHS collaborations may not be captured in this tool, whilst some non-NHS HCO partnerships may have been captured. Users are encouraged to consult the full Disclosure UK database for a more accurate and comprehensive overview of industry/HCO collaborations. Please note, Disclosure UK data for 2022 is now available. The latest data will be made available via the Pharma Impact Map later this year.  

Source URL:

https://www.disclosureuk.org.uk/

 

Value generated for NHS organisations through industry collaborations

Data source(s)

Data details

ABPI Disclosure UK data

Healthcare organisation 2021 disclosure data

Methodology:

  1. Total contribution calculation. The total contribution to the NHS is determined by summing two components, the collaborative working amount, and donations and grants given to the NHS organisation.

  2. The postcode of the NHS organisation that receives the contribution is used for geographical mapping.

 

Research

Research sites

Data source(s)

Data details

Bioscience and health technology sector statistics (BaHTSS) dataset.

BaHTSS 2021 site-level data provides detailed information about sites within the bioscience and health technology sector.

Methodology:

  1. To identify biopharmaceutical R&D sites, a filter was applied to identify biopharmaceutical companies. The data was then filtered to specifically focus on research and development (R&D) sites.

  2. The site postcode information available in the dataset was used for geographical mapping purposes at a local and regional level.

Source URL:

https://www.gov.uk/government/statistics/bioscience-and-health-technology-sector-statistics-2021

 

Clinical trial enrolment

Data source(s)

Data details

Data as reported by the NIHR CRN, NRS, HCRW, and NICRN (2022/23) and published in the ABPI’s report “Getting back on track: Restoring the UK’s global position in industry clinical trials”

The data was from 2022/23 and at LCRN level for England and regional level for Scotland, Northern Ireland, and Wales.

Methodology:

  1. Mapping of Local Clinical Research Networks (LCRN). A mapping was created to link the local clinical research networks to their respective UK regions.

  2. The clinical trial recruitment data was aggregated at the UK region level.

Source URL:

https://www.abpi.org.uk/publications/getting-back-on-track-restoring-the-uk-s-global-position-in-industry-clinical-trials/

 

References:

[1] Fraser of Allander Institute The economic contribution of the Pharmaceuticals Sector in Scotland (2023). Available at: https://fraserofallander.org/wp-content/uploads/2023/02/The-Economic-Contribution-of-the-Pharmaceutical-Sector-to-Scotlands-Economy-2023.pdf

 

[2] Fraser of Allander Institute The Economic Contribution of the Pharmaceuticals Sector in Northern Ireland (2022). Available at: https://fraserofallander.org/wp-content/uploads/2022/05/FAI-The-economic-contribution-of-the-pharmaceutical-sector-in-Northern-Ireland-FOR-SHARING.pdf

 

[3] GOV.UK. (n.d.). Bioscience and health technology sector statistics 2021. [online] Available at: https://www.gov.uk/government/statistics/bioscience-and-health-technology-sector-statistics-2021.

 

[4] The Scottish Government (2022) Scotland’s labour market: People, places, and regions – protected characteristics. statistics from the annual Population Survey 2021, Scottish Government. Available at: https://www.gov.scot/publications/scotlands-labour-market-people-places-regions-protected-characteristics-statistics-annual-population-survey-2021/  (Accessed: 05 January 2024).

Last modified: 05 March 2024

Last reviewed: 05 March 2024